Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymosin-alpha-1

Thymalfasin, Zadaxin, Thymosin α1

Quick Stats
Studies 759
Trials 63
Score 3
2010 pubmed 20 citations

Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.

Matteucci. Claudia C; Minutolo. Antonella A; Sinibaldi-Vallebona. Paola P; Palamara. Anna Teresa AT; Rasi. Guido G; Mastino. Antonio A; Garaci. Enrico E

Key Findings

  • Thymosin‑alpha‑1 significantly alters the transcription of hundreds of genes in peripheral blood mononuclear cells
  • The analysis uncovered many genes newly identified as responsive to thymosin‑alpha‑1
  • The results highlight thymosin‑alpha‑1 as a wide‑range regulator of lymphocyte function and immune responses

Practical Outcomes

  • For biohackers, the data suggest thymosin‑alpha‑1 can modulate immune pathways at the genetic level, hinting at potential benefits for immune support. However, the study provides no dosing or protocol guidance, so any use should be experimental and paired with further safety research.

Summary

The study examined how thymosin‑alpha‑1 changes gene activity in human immune cells grown in a lab. It found that the peptide switches on and off many genes, including several not previously linked to it, showing it can broadly influence both innate and adaptive immunity.

Abstract

Thymosin alpha-1 (Talpha1) is a molecule retaining pleiotropic effects toward several pathological conditions, especially acting as a modulator of immune response and inflammation. However, molecular mechanisms underlying the peculiar, wide-range activity of Talpha1 have not been completely elucidated. To get information on the mechanism of action of Talpha1 and to find new potential applications, we performed the analysis of the transcription profile of 8300 genes in human peripheral blood mononuclear cells in vitro treated with Talpha1. Together with a variety of genes already known to be modulated by Talpha1, our analysis revealed a remarkable number of genes not yet described before to be modulated by this thymic peptide, revealing a complex scenario that underlines the role of this peptide as a regulator of lymphocyte functions. Here, we report the list of the more representative modulated genes and discuss their implications on the modulation of the innate and adaptive responses. Our results open new perspectives on the use of Talpha1 for the treatment of diseases associated with immune-disregulation.

Study Information

Provider

pubmed

Year

2010

Date

2010-05-01T00:00:00.000Z

DOI

10.1111/j.1749-6632.2010.05484.x

Citations

20

References

66